Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo

Fertility and Sterility

Volumn 96, Issue 4, 2011, Pages

  Xu, Hui ^a   Becker, Christian M ^b   Lui, Wai Ting ^a   Chu, Ching Yan ^a   Davis, Tina N ^c   Kung, Andrew L ^c   Birsner, Amy E ^c   D'Amato, Robert J ^c   Wai Man, Gene Chi ^a   Wang, Chi Chiu ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

antiangiogenesis; Endometriosis; green tea catechins

Indexed keywords

ALPHA TOCOPHEROL; ANGIOGENESIS INHIBITOR; CXCL3 CHEMOKINE; EPIGALLOCATECHIN GALLATE; GAMMA INTERFERON; GELATINASE B; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN C JUN; VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 2;

ADENOMYOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG SCREENING; ENDOMETRIUM; ENDOTHELIUM CELL; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROVASCULATURE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SCID MOUSE; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 80053329018     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2011.07.008     Document Type: Article

References (36)

1. B. Eskenazi, and M.L. Warner Epidemiology of endometriosis Obstet Gynecol Clin North Am 24 1997 235 238
2. K. May, and C.M. Becker Endometriosis and angiogenesis Minerva Ginecol 60 2008 245 254
3. P.G. Groothuis, A.W. Nap, E. Winterhager, and R. Grümmer Vascular development in endometriosis Angiogenesis 8 2005 147 156 (Pubitemid 41712844)
4. V.M. Rice Conventional medical therapies for endometriosis Ann N Y Acad Sci 955 2002 343 352 (Pubitemid 34271092)
5. M.L. Hull, D.S. Charnock-Jones, C.L. Chan, K.L. Bruner-Tran, K.G. Osteen, and B.D. Tom Antiangiogenic agents are effective inhibitors of endometriosis J Clin Endocrinol Metab 88 2003 2889 2899 (Pubitemid 36733546)
6. A.W. Nap, A.W. Griffioen, G.A.J. Dunselman, J.C.A. Bouma-Ter Steege, V.J.L. Tijssen, and J.L.H. Evers Antiangiogenesis therapy for endometriosis J Clin Endocrinol Metab 89 2004 1089 1095 (Pubitemid 38368395)
7. M.L. Heiss, and R.J. Heiss The story of tea 2007 Ten Speed Press Berkeley
8. T. Yamamoto Chemistry and applications of green tea 1997 CRC Press Boca Raton, FL
9. D.G. Nagle, D. Ferreira, and Y.D. Zhou Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives Phytochemistry 67 2006 1849 1855 (Pubitemid 44291411)
10. Y.H. Cao, and R.H. Cao Angiogenesis inhibited by drinking tea Nature 398 1999 381
11. H. Xu, W.T. Lui, C.Y. Chu, P.S. Ng, C.C. Wang, and M.S. Rogers Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model Hum Reprod 24 2009 608 618
12. Revised American Society for Reproductive Medicine classification of endometriosis: 1996 Fertil Steril 67 1997 817 821
13. K.L. Bruner-Tran, K.G. Osteen, and A.J. Duleba Simvastatin protects against the development of endometriosis in a nude mouse model J Clin Endocrinol Metab 94 2009 2489 2494
14. B. Martinez Villayandre, M.A. Paniagua, A. Fernandez-Lopez, M.A. Chinchetru, and P. Calvo Effect of vitamin E treatment on N-methyl-d-aspartate receptor at different ages in the rat brain Brain Res 1028 2004 148 155 (Pubitemid 39446626)
15. S. Sang, J.D. Lambert, J. Hong, S. Tian, M.J. Lee, and R.E. Stark Synthesis and structure identification of thiol conjugates of (-)-epigallocatechin gallate and their urinary levels in mice Chem Res Toxicol 18 2005 1762 1769 (Pubitemid 43257759)
16. K.Y. Lin, M. Maricevich, N. Bardeesy, R. Weissleder, and U. Mahmood in vivo quantitative microvasculature phenotype imaging of healthy and malignant tissues using a fiber-optic confocal laser microprobe Transl Oncol 1 2008 84 94
17. K.H. Al-Gubory Fibered confocal fluorescence microscopy for imaging apoptotic DNA fragmentation at the single-cell level in vivo Exp Cell Res 310 2005 474 481 (Pubitemid 41457349)
18. R. Dardik, J. Loscalzo, R. Eskaraev, and A. Inbal Molecular mechanisms underlying the proangiogenic effect of factor XIII Arterioscler Thromb Vasc Biol 25 2005 526 532 (Pubitemid 40315673)
19. S.A. Gerber, B. Yatsula, C.L. Maier, T.J. Sadler, L.W. Whittaker, and J.S. Pober Interferon-gamma induces prolyl hydroxylase (PHD)3 through a STAT1-dependent mechanism in human endothelial cells Arterioscler Thromb Vasc Biol 29 2009 1363 1369
20. M.A. Moses The regulation of neovascularization of matrix metalloproteinases and their inhibitors Stem Cells 15 1997 180 189 (Pubitemid 27225283)
21. R.N. Taylor, D.I. Lebovic, and M.D. Mueller Angiogenic factors in endometriosis Ann N Y Acad Sci 955 2002 89 100 (Pubitemid 34271066)
22. M. Nisolle, F. Casanas-Roux, V. Anaf, J.M. Mine, and J. Donnez Morphometric study of the stromal vascularization in peritoneal endometriosis Fertil Steril 59 1993 681 684 (Pubitemid 23086336)
23. M.W. Laschke, and M.D. Menger in vitro and in vivo approaches to study angiogenesis in the pathophysiology and therapy of endometriosis Hum Reprod Update 13 2007 331 342 (Pubitemid 47062827)
24. J. McLaren Vascular endothelial growth factor and endometriotic angiogenesis Hum Reprod Update 6 2000 45 55 (Pubitemid 30099342)
25. J. Donnez, P. Smoes, S. Gillerot, F. Casanas-Roux, and M. Nisolle Vascular endothelial growth factor (VEGF) in endometriosis Hum Reprod 13 1998 1686 1690 (Pubitemid 28310515)
26. M. Takehara, M. Ueda, Y. Yamashita, Y. Terai, Y.C. Hung, and M. Ueki Vascular endothelial growth factor A and C gene expression in endometriosis Hum Pathol 35 2004 1369 1375 (Pubitemid 39601577)
27. C.S. Yang, X. Wang, G. Lu, and S.C. Picinich Cancer prevention by tea: animal studies, molecular mechanisms and human relevance Nat Rev Cancer 9 2009 429 439
28. M.W. Laschke, C. Schwender, C. Scheuer, B. Vollmar, and M.D. Menger Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo Hum Reprod 23 2008 2308 2318
29. V. Joukov, T. Sorsa, V. Kumar, M. Jelisch, L. Claesson-Welsh, and Y. Cao Proteolytic processing regulates receptor specificity and activity of VEGF-C EMBO J 16 1997 3898 3911 (Pubitemid 27281006)
30. M. Jeltsch, A. Kaipainen, V. Joukov, X. Meng, M. Lakso, and H. Rauvala Hyperplasia of lymphatic vessels in VEGF-C transgenic mice Science 76 1997 1423 1425 (Pubitemid 27235412)
31. V. Joukov, K. Pajusola, A. Kaipainen, D. Chilov, I. Lahtinen, and E. Kukk A novel endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases EMBO J 15 1996 290 298 (Pubitemid 26029207)
32. P. Nyberg, L. Xie, and R. Kalluri Endogenous inhibitors of angiogenesis Cancer Res 65 2005 3967 3979 (Pubitemid 40775631)
33. N. Klauber, R.M. Rohan, E. Flynn, and R.J. D'Amato Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470 Nat Med 3 1997 443 446 (Pubitemid 27145687)
34. C.M. Becker, D.A. Sampson, M.A. Rupnick, R.M. Rohan, J.A. Efstathiou, and S.M. Short Endostatin inhibits the growth of endometriotic lesions but does not affect fertility Fertil Steril 2005 5(84 Suppl 2):1144-55
35. Y.H. Cao, R.H. Cao, and E. Brkenhielm Antiangiogenic mechanisms of diet-derived polyphenols J Nutr Biochem 13 2002 380 390
36. R. Cooper, D.J. Morré, and D.M. Morré Medicinal benefits of green tea: part I. Review of noncancer health benefits J Altern Complement Med 11 2005 521 528 (Pubitemid 41001422)